Please login to the form below

Not currently logged in
Email:
Password:

drug licensing

This page shows the latest drug licensing news and features for those working in and with pharma, biotech and healthcare.

UK and EU’s future relationship ‘must protect patients’

UK and EU’s future relationship ‘must protect patients’

There will also be reciprocal arrangements on drug licensing dossiers, but the future role of the MHRA remains under a cloud as it can no long take the lead on marketing

Latest news

  • Plasticell and London’s gene therapy pioneers to tackle manufacturing conundrum Plasticell and London’s gene therapy pioneers to tackle manufacturing conundrum

    This is an excellent opportunity to improve the manufacturing technology as we move towards drug licensing” commented Professor Adrian Thrasher, Fellow at the UCL Great Ormond Street Institute of Child Health.

  • Novo Nordisk pays $400m for EpiDestiny’s sickle cell drug Novo Nordisk pays $400m for EpiDestiny’s sickle cell drug

    Novo Nordisk has bolstered its biopharma unit with a global licensing deal for a small-molecule drug for genetic blood disorders sickle cell disease and beta thalassaemia. ... II/III trials of the drug in oncology before the end of the year.

  • Onyx Health wins two new accounts

    The marketing communications agency will strengthen Newcells’ position in the drug discovery outsourcing market. ... Dr Mike Nicholds, chief executive officer at Newcells Biotech, said: “A new drug can take on average over ten years from initial

  • European Commission approves Dompé’s orphan drug European Commission approves Dompé’s orphan drug

    The approval comes at a big win for the biotech as the product was designated as an orphan drug back in 2015, and until now there have been no authorised biotechnological ... Aringhieri added: “Oxervate is our first biotech drug and its licensing is

  • Marathon pauses Emflaza launch amid pricing furore Marathon pauses Emflaza launch amid pricing furore

    They want information on the cost of trials as well as licensing rights to the drug, the calculations used for setting its price and estimates of how much revenue Marathon intends ... It added that it would continue its expanded access programme for the

More from news
Approximately 1 fully matching, plus 53 partially matching documents found.

Latest Intelligence

  • ‘Flexible working’: fashionable buzzword or fundamental business operation? ‘Flexible working’: fashionable buzzword or fundamental business operation?

    Externally, there are the usual issues: downward pressure on hourly rates, reduced client budgets, environmental pressures on new drug development and licensing/reimbursement.

  • Charting a course for expansion Charting a course for expansion

    a key licensing agreement and the not inconsequential matter of a management reshuffle. ... Cabometyx accelerates. Earlier this year Ipsen signed another deal to bolster its pipeline by harnessing external innovation, licensing promising cancer drug

  • Pharma deals during January 2013 Pharma deals during January 2013

    Out licensing WW rights to RN 307 antibody (binds to calcitonin related peptide) phase II ready. ... 18-MC (18-methoxycoronaridine) as a treatment for drug addiction, obesity and compulsive behaviour.

  • Modern anticoagulants threaten status quo Modern anticoagulants threaten status quo

    However, Sanofi has since discontinued its development. The company announced in May 2011 that the drug is available for licensing. ... The drug is also in phase III development for the acute treatment of VTE.

More from intelligence
Approximately 1 fully matching, plus 3 partially matching documents found.

Latest appointments

  • Ipsen bolsters leadership team Ipsen bolsters leadership team

    Prior to this, she has served as senior vice president, head of global business development at Teva Pharmaceuticals, where she led and executed multiple business development transactions ranging from licensing to ... acquisition of drug candidates,

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • Drivers of 2014′s Soaring Drug Approvals

    The FDA &EMA approved a chart-topping number of new drugs in 2014. Read more in our White Paper about the responsibility this growing approval success will put on future launch teams and some of the key areas of focus which could make or break a

More from PMHub
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Ashfield

Ashfield, part of UDG Healthcare plc, is a global leader in commercialisation services for the healthcare industry. We partner with...

Latest intelligence

Unlocking the potential of science and technology in the UK
Greater collaboration is vital in post-Brexit UK, says Alderley Park leader...
NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...

Infographics